Further analysis of mutual exclusivity showed that only one gene pair (NOTCH1-RELA) exhibited significant co-occurrence (p < 0.05) in the breast cancer study by the INSERM 2016 project (Table 2), which indicated the pivotal role of NOTCH1 and RELA under tangeretin treatment. The gene discussed is RELA; the disease is breast cancer.